Untreated White Coat Hypertension May Up Cardiovascular Risk
Treated white coat effect not tied to cardiovascular events or all-cause, cardiovascular mortality
Hypertension
HYPERTENSION
Potassium Binder May Enable Optimal RAASi Use in CKD
In a study, 87% of hyperkalemic patients on renin-angiotensin-aldosterone system inhibitor (RAASi) therapy were able to continue or increase their RAASi doses while concurrently taking sodium zirconium cyclosilicate.
Higher FGF23 Predicts Worse Clinical Parameters in HF With Preserved EF
Fibroblast growth factor 23 levels above the median are independently associated with shorter 6-minute walk distance and lower peak oxygen consumption on exercise testing, study finds.
Work Stress, Impaired Sleep Tied to CVD Risk in Workers With Hypertension
Highest risk for cardiovascular disease mortality seen for those with work stress and impaired sleep
Prostate Cancer Incidence Lower Among Atenolol Users
Users of atenolol had 59% and 55% decreased odds of intermediate- and high-risk prostate cancer being found on biopsy compared with nonusers.
Intensive Blood Pressure Therapy Aids Patients With T2DM
Overall death from any cause reduced, regardless of cardiovascular risk
Sleeping Pill Use Tied to Greater Need for BP Meds in Older Adults
But no association observed between sleep duration or quality and change in BP drug use
Intensive Blood Pressure Control May Cut Mortality in CKD
Targeting a systolic blood pressure below 130 mm Hg was associated with a 21% decreased risk of all-cause mortality among patients with stage 3 to 4 chronic kidney disease, a meta-analysis found.
Intensive BP Lowering May Up Cognitive Decline in Elderly
For those on antihypertensive treatment, cognitive decline greater with SBP <130 versus >150 mm Hg
Normalizing BP in Elderly With Hypertension May Up Mortality
Blood pressure values less than 140/90 mm Hg tied to increased mortality risk for octogenarians
Want to read more?
Please login or register first to view this content.
Next post in News
